Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.20.2
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid in Capital [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total
Beginning balance at Dec. 31, 2018 $ 48,562 $ 83,728,903 $ (84,826,796) $ (37,117) $ (24,340) $ (1,110,788)
Beginning balance, shares at Dec. 31, 2018 4,856,213     1,048    
Sale of common stock $ 7,370 1,590,445 1,597,815
Sale of common stock, shares 737,031        
Conversion of note payable - related party $ 2,092 497,908 500,000
Conversion of note payable - related party, shares 209,205        
Issuance of common stock for settlement of acounts payable $ 306 98,664 98,970
Issuance of common stock for settlement of acounts payable, shares 30,640        
Issuance of vested restricted shares $ 278 (278)
Issuance of vested restricted shares, shares 27,761        
Share-based compensation 98,689 98,689
Translation adjustments 13,686 13,686
Net loss (1,930,603) (1,930,603)
Ending balance at Jun. 30, 2019 $ 58,608 86,014,331 (86,757,399) $ (37,117) (10,654) (732,231)
Ending balance, shares at Jun. 30, 2019 5,860,850     1,048    
Beginning balance at Dec. 31, 2019 $ 89,286 91,126,784 (88,671,260) $ (37,117) 44,242 2,551,935
Beginning balance, shares at Dec. 31, 2019 8,928,611     1,048    
Sale of common stock $ 22,518 1,477,482 1,500,000
Sale of common stock, shares 2,251,737        
Issuance of vested restricted shares $ 1,580 (1,580)
Issuance of vested restricted shares, shares 158,011        
Share-based compensation 397,599 397,599
Translation adjustments 28,105 28,105
Net loss (3,330,968) (3,330,968)
Ending balance at Jun. 30, 2020 $ 113,384 $ 93,000,285 $ (92,002,228) $ (37,117) $ 72,347 $ 1,146,671
Ending balance, shares at Jun. 30, 2020 11,338,359     1,048